Novavax, Inc. (NVAX) Reports In-Line Q1 EPS, Misses Revenue Expectations
Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $834 thousand versus the consensus estimate of $2.29 million.